NEW YORK — A proteome-wide association study has uncovered new genes that may cause depression when their protein levels change in the brain, including proteins that could be treatment targets.
Major depressive disorder affects about 264 million people around the global, according to the World Health Organization. While there are treatments for depression, they are only effective in a subset of patients.